Cover Image

Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke

Non-vitamin K antagonist oral anticoagulants (NOACs) have gained increasing importance for stroke prevention in patients with non-valvular atrial fibrillation (AF). With changing prescription practice, among other factors, clinicians can expect to see rising numbers of patients with ischemic stroke...

Full description

Saved in:
Bibliographic Details
Main Authors: Hoyer, Carolin (Author) , Filipov, Alexandra (Author) , Neumaier-Probst, Eva (Author) , Szabo, Kristina (Author) , Ebert, Anne (Author) , Alonso, Angelika (Author)
Format: Article (Journal)
Language:English
Published: 23 February 2018
In: Journal of thrombosis and thrombolysis
Year: 2018, Volume: 45, Issue: 4, Pages: 529-535
ISSN:1573-742X
DOI:10.1007/s11239-018-1634-1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11239-018-1634-1
Get full text
Author Notes:Carolin Hoyer, Alexandra Filipov, Eva Neumaier-Probst, Kristina Szabo, Anne Ebert, Angelika Alonso
Description
Summary:Non-vitamin K antagonist oral anticoagulants (NOACs) have gained increasing importance for stroke prevention in patients with non-valvular atrial fibrillation (AF). With changing prescription practice, among other factors, clinicians can expect to see rising numbers of patients with ischemic stroke and pre-existing NOAC therapy. Few data exist regarding a potential impact of NOAC on stroke severity and outcome.
Item Description:Gesehen am 07.09.2020
Physical Description:Online Resource
ISSN:1573-742X
DOI:10.1007/s11239-018-1634-1

Similar Items